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Abstract: In screening endophytic fungi from Costa Rica for bioactivity, fungal culture CR200, 
isolated from a buttonwood tree, was found to contain compounds that initiate DNA damage in a 
test strain of E. coli (Biochemical Induction Assay, BIA) and inhibit growth of Gram-positive 
bacteria, including antibiotic-resistant strains. Two new bisanthraquinones (cytoskyrins A and B) 
and five new related octaketides (cytosporones A-E) were isolated from fermentation broths of 
this fungus. Cytoskyrin A exhibited potent in-vitro antibacterial (MICs against Gram-positive 
bacteria, 0.03 - 0.25 μg/mL) and DNA-damaging activities (10 ng/spot), whereas cytoskyrin B 
was inactive in these assays. Among the cytosporones, only D and E exhibited Gram-positive 
activity, but they were inactive in the BIA. Mechanistically, cytoskyrin A specifically inhibited 
DNA synthesis in E. coli imp at its MIC; however, it also moderately inhibited protein synthesis 
at 2x its MIC. Cytoskyrin A exhibited poor cytotoxicity against tumor cell lines (IC50 > 5 μg/mL) 
compared to known antitumor agents. The nuclear ribosomal internal transcribed spacer region of 
CR200 was found to share highest similarity (94-96%) with Cytospora spp. Micro- and 
macroscopic morphological observations of the conidia and conidiomata, respectively, also 
suggested this fungus to be a Cytospora sp. 
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1.  Introduction  
 
Fungi, one of the most diverse groups of organisms, are known to produce a wide variety of 
medically important metabolites. Of the 1.5 million species estimated to be in existence only a small 
fraction (ca. 1%) have been studied [1]. In our continued efforts to discover novel compounds from 
filamentous fungi, culture CR200, obtained from a Costa Rican buttonwood tree, was found to be 
active in the Biochemical Induction Assay (BIA), which detects compounds that initiate DNA damage
 
[2] and against a panel of antibiotic-resistant bacteria. As previously reported, two new 
bisanthraquinones (cytoskyrins A and B, Figure 1) and five new related octaketides (cytosporones A-
E) were isolated from fermentation broths of this culture [3, 4]. Since then similar bisanthraquinones 
have been isolated from a number of different fungi [5, 6] and even synthesized [7-10]. In this paper, 
we report the biological activities of the isolated compounds as well as the taxonomy and fermentation 
of CR200. Some of these findings were previously presented at the 40
th Interscience Conference on 
Antimicrobial Agents and Chemotherapeutic Agents and the Society for Industrial Microbiology 
meetings [11, 12].  
 
Figure 1. Chemical structures of cytoskyrins and related bisanthraquinones, and cytosporones. 
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2. Results and Discussion 
 
Culture Morphology 
 
Growth of CR200 on potato dextrose agar (PDA), cornmeal agar (CMA) and Leonian’s agar (LA) 
were examined. The organism grew rather well on all three media, but the most differentiation and 
texture occurred on PDA (Table 1). CR200 grew robustly on PDA at 22°C reaching a diameter of 74 
mm after only 7 days of growth and a maximum of 81 mm by 14 days (Figure 2A). Surface 
morphology was generally floccose to felty throughout the incubation period. Colony color progressed 
from white to taupe and buff with some yellow-brown at the colony center. Conidiomata (pycnidia) 
were visible by day 14 as white to light brown dots partially submerged into the agar (Figure 2A). By 
the 21
st to 28
th days, some conidiomata appeared dark brown (Figures 2B). About five to ten percent of 
them oozed a spore mass as yellow cirrhi in globules (Figures 2C) while others leaked a clear to 
brownish exudate. The conidiomata displayed elongated necks/beaks, some of them with extensive 
branching after an extended incubation of six weeks to several months.  
 
Figure 2. Morphological characteristics of culture CR200 grown on PDA for 14 days 
(A), PDA for 28 days (B), enlarged view of the boxed area on B (C), CR200 phase 
contrast image of conidioma excised from a 28 day culture (D), and phase contrast image 
of conidiogenous cells with collerettes and a conidium (bar = 2.0 µm) (E). 
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Table 1. Morphological characteristics in different fungal media. 
Medium 
Temp 
(ºC) 
Day 
Size 
(mm) 
Color top and reverse, 
same if not indicated 
Morphology 
PDA  22  7  74  top: yellow-brown to 
white; reverse: gray-
yellow to white 
floccose to felty with submerged 
mycelia at margins 
    14  81  top: taupe to buff; reverse: 
taupe to yellow-gray  
floccose to felty with frequent 
conidiomata forming near margins 
    21  81  top: taupe to beige to 
buff; reverse: yellow-gray
felty, floccose to fuzzy with 
submerged mycelia and frequent 
conidiomata 
CMA 22 7  58  translucent  moist,  flat,  wispy 
    14  76  translucent  thin, moist, smooth 
    21  78  translucent to pale yellow thin, moist, smooth 
LA  22  7  82  translucent  flat, moist, radiate 
    14  83  light olive-gray to 
translucent 
thin, moist, smooth with some large 
submerged conidiomata 
    21  83  light olive-gray to 
translucent 
thin, moist, smooth with some large 
submerged conidiomata 
PDA  33  7  26  yellow-brown to white  low raised, fuzzy, leathery to felty 
    14  33  top: light brown to tan-
gray to white; reverse: 
red-brown 
floccose, powdery with sulcated margin 
and soluble red-brown pigment 
    21  42  top: brown to taupe to 
light tan; reverse: medium 
brown to orange-brown  
dusty, felty to floccose with sulcation at 
margins and brown soluble pigment 
CMA 33 7  30  white  flat,  radiate,  moist 
    14  44  translucent  thin, smooth, moist 
    21  56  light buff to translucent  thin, smooth, moist with submerged 
mycelia 
LA  33  7  28  brown to tan to white  moist, leathery 
    14  46  red-brown to buff  leathery, gritty to smooth, submerged 
mycelia 
    21  57  medium brown to dark tan 
to buff 
smooth leathery to slightly gritty with 
submerged mycelia 
 
CR200 grew most rapidly on LA, but remained flat or submerged in the agar. Mycelia were 
colorless or translucent becoming light olive-gray by day 14. Conidiomata also formed on LA by day 
14, but were completely submerged, olive-gray and larger than those that formed on PDA. 
CR200 grew more slowly on all three media at 33°C. The growth stress at the higher temperature 
was indicated by altered morphologies. On PDA, a red-brown to brown soluble pigment was produced, Mar. Drugs 2007, 5                                                  
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while on LA both the surface and reverse displayed red-brown to brown pigmentation. Conidiomata 
did not form on any media at 33°C. Conidiophores were hyaline, unbranched to highly branched at the 
base and/or mid-height and formed a continuous layer (Figure 2D, E). Conidiogenous cells were 
enteroblastic, phialidic, tapering to the apices with collerettes up to 2 µm long (Figure 2E). Conidia 
were hyaline, allantoid and measured about 5 to 6 μm long and 1.5 μm wide (Figure 2E).  
 
Phylogenetics 
 
The ITS of CR200 was found to be 517 bp in length. A BLAST search of the ITS of CR200 
revealed that it is most similar to C. acaciae (96%). A phylogenetic tree (Figure 2) of the ITS of 22 
Cytospora spp. placed CR200 in a clade with C. acaciae,  C. rhizophorae,  C. nitschkii, and C. 
abyssinica. However, CR200 branched deeply from C. acaciae (supported by 69 bootstrap replicates), 
indicating that it is a distinct species. 
 
Figure 2. ITS region phylogenetic tree of CR200, bootstrap values above 50 appear at nodes. 
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Fermentation 
Production of cytoskyrin A as measured by BIA activity was quite heterogeneous in the 100-flask 
fermentation. Approximately 87% of the flask fermentations were active in the BIA, with 42% 
displaying very good activity and 45% with fair to poor activity. The remaining 13% of the flask 
fermentations did not exhibit activity in the BIA, suggesting no production of cytoskyrin A. Separation 
of the cells from the broth and extraction of both with ethyl acetate revealed that the majority of 
cytoskyrin A was associated with the cells, but is also present in the fermentation broths. The higher 
shaking speed of 200 rpm produced activity detected by the BIA sooner than the lower shaking speed 
of 100 rpm, whether incubated at 22°C or 28°C. Interestingly, BIA activity was not detected from the 
whole broths of CR200 fermented at 22°C and 100 rpm, even after 21 days of incubation. 
 
Biological activities 
 
DNA-damaging activities of the CR200 fermentation broth and pure compounds were tested by the 
biochemical induction assay (BIA). Cytoskyrin A demonstrated a minimum inducing concentration of 
12 ng/spot in this assay, suggesting this compound as a potent DNA-damaging agent in bacteria (Table 
2). Related bisanthraquinones such as rugulosin and luteoskyrin, known DNA intercalating agents, 
were toxic but did not induce the positive BIA response under the used assay conditions. These agents 
exhibit induction in the BIA only after a prolonged preincubation period. Cytoskyrin B, also produced 
by CR200, was inactive in the BIA. Cytoskyrin A appears to have the structural requirements to 
exhibit potent DNA-damaging activity in bacteria. Cytoskyrin A also exhibited excellent activity 
against the Gram-positive bacteria and the E. coli imp. However, it did not have activity against other 
Gram-negative bacteria, indicating that it may have difficulty crossing the outer membrane barrier 
(Table 3). Cytoskyrin B was inactive against the bacterial isolates tested (Tables 2 and 3). Minor 
differences in the chemical structures appear to affect the bioactivity of this class of compound (Figure 
1). Among the five novel cytosporones A-E isolated from the CR200 fermentations, only D and E 
were active against Gram-positive bacteria and yeast (Table 3).  
Table 2. BIA activity of Cytoskyrins and known anticancer drugs. 
Concentration  
(μg/spot) 
Cytoskyrin      
A            B 
Rugulosin Luteoskyrin Bleomycin Mitomycin  C  Doxorubicin
100 1+:T  0 T  T  1+:T  nt  nt 
25 1+:T  0 T  T  1+:T  nt  nt 
2.5  3+  0 T  T  3+ 1+:11T 2+ 
1.25 3+  0 T  T  3+ 2+:10T 1+ 
0.6 3+  0  T  T  3+ 2+:7T +/- 
0.3 3+  0  T  T  3+  2+  0 
0.15 2+  0  T  T  3+  2+  0 
0.08 +/-  0 T  T  2+  1+  0 
Test organism is E. coli with a lambda lysogen whose PL promoter is fused to lacZ 
T = toxic zone, nt = not tested, 0 = inactive 
3+ to +/- = level of β-galactosidase induction from strongest to weakest 
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Table 3.  Antimicrobial Activity of Cytoskyrins and Cytosporones. 
Organism 
MIC (MBC) in μg/mL 
Cytoskyrin A  Cytosporone D  Penicillin G 
S. aureus ATCC 29923  0.031  8  <.062 
S. aureus ATCC6538P  0.06 (0.12)  8  <.062 
S. aureus #310 (MRSA)  0.03 (0.06)  8  64 
E. faecium #379 (VREF)  0.25  16  32 
E. faecium #436 (VSEF)  0.12  16  2 
B. subtilis BGGS1A1  < 0.06 (0.06)  16  0.125 
E. coli imp BAS849  0.12 (1)  64  2 
E. coli BAS849  >128  128  32 
E. coli ATCC25922  >64  64  16 
K. pneumoniae ATCC 10031  >64  64  16 
P. aeruginosa ATCC 27079  >64  >128  >64 
C. albicans #54  16  4  >128 
Test organisms #310 (methicillin-resistant), #379 (vancomycin-resistant), #436 (vancomycin-
sensitive), and #54 are clinical isolates maintained in our lab. MIC of cytosporone E was same as 
cytosporone D. Cytoskyrin B and cytosporones A, B and C were inactive at the highest 
concentration tested.   
 
Inhibition of DNA, RNA, and protein synthesis was determined by measuring the incorporation of 
3H-Tdr,  3H-Udr, and 3H-AA, respectively, into TCA-precipitable material of a logarithmic-phase 
culture of E. coli imp. Control drugs affected the anticipated macromolecular processes (Table 4). 
Cytoskyrin A specifically inhibited the incorporation of 
3H-thymidine into DNA (Table 4). 
Incorporation of amino acids into protein was also affected at higher concentrations. Based on the BIA 
activity and the specific inhibition of DNA synthesis in E. coli imp, cytoskyrin A appears to be a 
potent DNA-damaging agent. Since DNA-damaging agents also constitute an important class of 
anticancer drugs, cytoskyrin A was tested for antiproliferative activity against four human tumor cell 
lines and it was found to have moderate cytoxicity with IC50 values in the range of 4 to 24 μg/mL 
(Table 5).  
 
3. Conclusions 
 
The cytoskyrins and cytosporones isolated from Cytospora sp. CR200 were first disclosed as novel 
compounds in 2000 by Brady et al [3,4]. Since then other researchers have reported the production of 
similar compounds by several different fungi [5, 6]. Unlike the related compound luteoskyrin, 
cytoskyrin A exhibited potent activity in the bacterial BIA and is therefore capable of directly or 
indirectly initiating DNA damage. Selective inhibition of DNA synthesis (measured by the 
incorporation of radiolabeled thymidine) in E. coli further confirmed its mode of action. Unfortunately, 
cytoskyrin A was less toxic to human cell lines than luteoskyrin and could not be used as an anticancer 
agent. Although luteoskyrin and cytoskyrins are chemically related, the mechanisms-of-action of these 
compounds appear to be different in prokaryotic and eukaryotic cells. 
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Table 4. Effects on the incorporation of radiolabeled precursors into macromolecules in E. coli imp. 
Compound Conc.  (µg/mL)
3H-Tdr 
3H-Udr 
3H-AA 
Cytoskyrin A  2  3  102  54 
 1  6  98  66 
  0.50 19 100 89 
  0.25  97 95 94 
Ciprofloxacin 0.25  3  90  95 
Rifampin  0.25  93 2 12 
Chloramphenicol 8  98 95 16 
Polymyxin  B  8 1 2 3 
Data presented represent % of untreated control after 10 min drug treatment and 
5 min pulse labeling; Incorporation = precursor incorporated into TCA-
precipitable material; 
3H-Tdr, 
3H-Udr and 
3H-AA are tritiated thymidine, uridine 
and amino acids, respectively. 
 
Table 5. Cytotoxicity (IC50 in μg/mL) of Cytoskyrin A and known antitumor agents. 
Cell line (human)  Cytoskyrin 
A 
Luteoskyrin Taxol Adriamycin
Epidermoid Carcinoma A431  4.1-9.6  0.08  0.0064  0.09 
Breast Carcinoma SKBR3  5.2-24.3  0.12  0.0039  0.06 
Carcinoma MDA435  3.6-13.0  0.13  0.0034  0.33 
Colon Carcinoma SW620  5.2-16.6  0.18  0.0096  0.16 
 
CR200 was isolated as an endophyte from a tissue sample of a branch of Conocarpus erecta. 
Although the fruiting structures of this fungus were never observed on its host, morphology of CR200 
in culture and phylogenetic analysis of the ITS identified CR200 as a Cytospora sp. Further 
classification of CR200 to the species level would be difficult because no comprehensive keys are 
available for distinguishing Cytospora spp. in culture. Adams et al. [21] have shown that sequencing 
and comparative analysis of the ITS can be important to the identification of Cytospora spp., yet ITS 
data exists for less than 30 of the more than 300 species of Cytospora that have been described. 
Considering the importance of these fungi in the production of useful natural products such as 
antibiotics [22], angiotensin inhibitors [23] and HIV integrase inhibitors [24] efforts to sequence the 
ITS of validly described species would greatly aid in the future classification of Cytospora spp.  
 
4. Experimental  
 
Morphological Taxonomy 
 
Fungal culture CR200 was isolated from a branch of Conocarpus erecta (Buttonwood tree) in the 
Guanacaste National Park, Costa Rica (collection permit number 246.94). CR200 was streaked on 
Difco potato dextrose agar (PDA) and grown for 7-14 days at 22 ºC. Mycelia and conidia were washed 
with potato dextrose broth (PDB) containing 25 % glycerol, and 1 mL aliquots were transferred into Mar. Drugs 2007, 5                                                  
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cryovials for long-term storage at -140ºC at Wyeth Research, Pearl River, NY. An additional copy is 
kept at the repository of the National Institute of Biodiversity, INBio Code 12652. 
For macroscopic morphology, an agar plug of CR200 was placed in duplicate onto PDA, cornmeal 
agar (CMA, Oxoid) and Leonian’s agar (LA, 1.2 g KH2PO4, 0.6 g MgSO4, 6.25 g maltose, 6.25 g 
Difco malt extract, 15.0 g Bacto agar/L of distilled water) and the culture plates were incubated at 22 
°C and 33 °C. Colony morphology and size (in mm) were noted on the 7
th, 14
th, and 21
st days of 
incubation. For microscopic analysis, CR200 was grown on PDA for 21 days. The conidiomata were 
observed at 1x to 6.3x magnification under an Olympus brand stereoscope. A smash prep was prepared 
by aseptic excision of several conidiomata, which were placed on a microscope slide with water (10 
μL) and gently flattened with a coverslip. Microscopic observations were performed with an Olympus 
B071 phase-contrast microscope at 50x and 1,250x magnification. 
 
Molecular Taxonomy 
 
Isolation of the genomic DNA, PCR amplification and direct sequencing of the nuclear ribosomal 
ITS1-5.8S-ITS2 region have been described previously [13]. Briefly, mycelia (50-100 mg) were lysed 
in lysis buffer (0.5 mL, 2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA). 
Proteins were precipitated by the addition of 25:24:1 phenol/chloroform/isoamyl alcohol (0.5 mL, 
Sigma). The aqueous and organic layers were separated by centrifugation at 14,000 rpm for 5 minutes. 
The aqueous layer was pipetted into a new microfuge tube and the DNA was precipitated by addition 
of 3 M sodium acetate (0.1 mL) and isopropanol (0.8 mL). The nuclear ribosomal ITS1-5.8S-ITS2 
region was amplified with primers ITS1 and ITS4 [14]. Amplification of the ITS was confirmed by gel 
electrophoresis. The PCR product was cleaned and sequenced directly with an ABI 3700 sequencer 
with the ABI Prism DNA sequencing kit and Big Dye terminators version 3.0 (Applied Biosystems). 
For this study, the ITS were sequenced for Cytospora sp. CR200, Cytospora cincta ATCC 32673, 
Cytospora chrysosperma ATCC 56609, Cytospora leucostoma ATCC 42549 (deposited as 
Leucostoma persoonii), Cytospora rhizophorae ATCC 38475, and Cytospora sacchari ATCC 32322 
and assigned the following GenBank accessions: DQ996039-DQ996044. 
To determine the most closely related fungi, the ITS of CR200 was compared to other sequences in 
the GenBank database by BLASTN 2.2.2 analysis. The ITS of CR200 and several Cytospora spp. 
(Table 6) were aligned in Clustal X 1.81 with the multiple alignment parameters set at default values. 
A phylogenetic tree (Figure 2) was generated in TREECON 1.3b [15] with the distances calculated 
according to the Jukes and Cantor [16] method and insertions and deletions not taken into account. 
Bootstrap values were calculated using 1,000 bootstrap samples, and neighbor-joining was used to 
infer tree topologies. The phylogenetic tree was rooted with Diaporthe phaseolorum.  
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Table 6. Cytospora spp. used in the phylogenetic analysis. 
Culture name  Isolate 
GenBank accession 
number 
Cytospora abyssinica  CMW 10181  AY347353 
Cytospora acaciae  CBS 468.6  DQ243804 
Cytospora austromontana  CMW 6735  AY347361 
Cytospora carbonacea  CBS 219.54  DQ243805 
Cytospora chrysosperma  ATCC 56609  DQ996043 
Cytospora cincta  ATCC 32673  DQ996041 
Cytospora diatrypelloidea  CMW 8549  AY347368 
Cytospora disciformis  CMW 6509  AY347374 
Cytospora eucalypticola  ATCC 56123  AF192314 
Cytospora eucalyptina  CMW 5882  AY347375 
Cytospora hariotti  CBS 195.49  DQ243807 
Cytospora leucostoma  ATCC 42549  DQ996042 
Cytospora minuta  CBS 134.25  DQ243808 
Cytospora mougeotii  ATCC 44994  AY347329 
Cytospora nitschkii  CMW 10184  AY347355 
Cytospora rhizophorae  ATCC 38475  DQ996040 
Cytospora rhodophila  ATCC 38695  DQ243809 
Cytospora ribis  CBS 187.36  DQ243810 
Cytospora sacchari  ATCC 32322  DQ996044 
Cytospora sp.  CR200 DQ996039 
Cytospora tritici  CBS 827.84  DQ243812 
Cytospora variostromatica  CMW 6766  AY347366 
Diaporthe phaseolorum  CBS 116018  AY745017 
 
Fermentation 
 
Fermentation of CR200 for the production of the cytoskyrins was performed in a 6-liter batch. For 
seed fermentation, culture mycelia grown for seven days on Bennetts’ agar (pH 7.0, containing per 
liter: dextrose 10 g, beef extract 0.77 g, yeast extract 1 g, NZ amine 2 g, agar 15 g) were scraped into 
thirty 25x150 mm Pyrex culture tubes each containing PDB (11 mL). Seed tubes were incubated for 
four days at 22 °C and 160 rpm. On the fourth day the contents of the seed tubes were combined into a 
sterile vessel and gently macerated to obtain a homogeneous inoculum. One hundred Erlenmeyer Mar. Drugs 2007, 5                                                  
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flasks (250 mL), each containing sterile PDB (60 mL) were inoculated with the seed culture (5% v/v), 
and fermented for 21 days at 24 °C and 200 rpm. Additional flasks (five flasks for each condition) 
were inoculated to study the effects of temperature (22 °C versus 28 °C) and aeration (shaking at 100 
rpm versus 200 rpm) on the production of cytoskyrin A, which was measured by testing whole broths 
in the BIA. Fermentation of CR200 for the production of the cytosporones was performed in a 10-liter 
batch. First-stage seed conditions were the same as described above except that only three seed tubes 
were inoculated. For the second stage, the contents of the seed tubes were added to PDB (500 mL in a 
2.8 L Fernbach flask) and incubated at 22°C, 200 rpm for three days. For production fermentation, 10 
L of PDB in a 10 L bioreactor (Bioflo 3000, New Brunswick Scientific) were inoculated at 5% v/v 
with second-stage and incubated at 24 °C, 350 rpm for 15 days.  
 
Bioactivities 
 
In vitro Antimicrobial Susceptibility Testing 
 
The minimum inhibitory concentrations (MICs) were determined by the microbroth dilution 
method [17, 18]. Briefly, inocula were adjusted to a density of 1x10
7 to 5x10
7 CFU/mL and 5 µL were 
added to minimal medium or Mueller-Hinton broth (MHB) (100 µL, containing the drug at 
concentrations ranging from 0.03 to 128 µg/mL) in the wells of a microtiter plate. The MIC was 
defined as the lowest concentration of the antibiotic that prevented visual turbidity after 18 h of 
incubation at 37 °C. 
 
Biochemical Induction Assay (BIA) 
 
A slightly modified version of the previously described agar plate BIA method was used [2]. 
Briefly, an overnight culture of E. coli BR513 grown in LBE broth (100 mL/500 mL Erlenmeyer flask) 
at 37 °C and 200 rpm was inoculated into molten soft agar (40 mL, 1 %) at 50 °C to give a final A600 of 
0.15 (1-3 x 10
7 cfu/mL). The inoculated soft agar was immediately poured onto a LBE agar base layer 
previously poured into a 9"x9" Nunc plate. After 15 min, five µL of each of the two-fold serially 
diluted solutions of the test compounds were spotted on the agar surface. The plate was incubated at 37 
°C for 3.5 h and then overlayed with soft-agar (40 mL), containing fast blue RR (87 mg) and 6-bromo-
2-naphthyl-β-D-galactopyranoside (BNG, 13 mg). A red-violet color produced around the sample spot 
was read as a positive response. 
 
Incorporation of Radiolabeled Precursors 
 
Macromolecular synthesis in E. coli imp, an outer membrane permeability mutant [19], was studied 
by measuring the incorporation of appropriate radiolabeled precursors into trichloroacetic acid (TCA)-
precipitable material [18]. E. coli imp was grown at 37 °C, 200 rpm in modified minimal medium (50 
mL medium/250 mL Erlenmeyer flask) to an A450 of 0.20. Aliquots (100 µL) were dispensed into 
microtiter wells containing antibacterial agents and the plates were incubated for 10 min at 37 °C with 
vigorous agitation. Cells were pulse-labeled for 5 min by adding the following radiolabeled precursors Mar. Drugs 2007, 5                                                  
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at the indicated final concentrations: 
3H-thymidine (Tdr), 2 µCi/ml with 0.05 µg unlabeled 
thymidine/mL; 
3H-Uridine (Udr), 2 µCi with 2.5 µg unlabeled uridine/mL; or 
3H-amino acid mixture 
(AA), 2.5 µCi/mL. To determine specific incorporation into DNA, RNA, and protein, chilled (4 °C) 
TCA (100 µL, 10%) supplemented with unlabeled precursors (0.5 mg/mL) was added to each well, 
and the plate was immediately refrigerated for 1 h. The precipitate was collected on a glass fiber filter 
(Wallac filtermat B, Wallac 1205-404) using a Skatron 96-well cell harvester (Model 11050) 
programmed for a 3 sec prewet with chilled DI water, a 12 sec wash with 5% chilled TCA and a 5 sec 
drying cycle. Filter mats were dried for 7 min at high power in a microwave oven (Quasar, 700 Watts), 
solid scintillant (MeltilexB, Pharmacia 1205-402) was applied, and the isotope that was retained on the 
filter was quantitated in an LKB Betaplate scintillation counter (Wallac 1205). The levels of 
incorporation of 
3H-Tdr, 
3H-Udr, and 
3H-AA were expressed as the percent of the untreated control. 
 
Antiproliferative Activity 
 
Four human carcinoma cell lines, A431 (epidermoid carcinoma), SKBR3 (breast carcinoma), 
MDA-MB-435 (breast carcinoma), and SW620 (colon carcinoma) were used for cell proliferation 
assay. All cell lines were obtained from the American Type Culture Collection (ATCC). Cells were 
maintained in RPMI-1640 medium supplemented with 5% fetal bovine serum. Cells were plated in 96-
well plates at the densities of 5.0x 10
4/mL. On the next day, compounds were dosed at 0.5, 5, 50, 500, 
and 5000 ng/mL range and cultured for 2 days. At the end of incubation, cell survival was determined 
by the sulforhodamine B assay as previously described [20]. The IC50 values were obtained from the 
growth curves. 
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